Aster Capital Management’s Yarrow Bioscience YARW Stock Holding History

Aster Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$71.6K	Buy	+3,179	New	+$108K	0.03%	521

Other funds holding YARW

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return

Hurley Capital New York $206M AUM 18.12% 1-Year Est. Return

Aster Capital Management's YARW Position: Q3 2026 in Review

Aster Capital Management opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 3,179 shares worth $71.6K. The stake represents 0.03% of the portfolio and ranks #521 among its holdings.

12 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

Aster Capital Management held 3,179 shares of Yarrow Bioscience worth $71.6K as of Q3 2026.
Yarrow Bioscience was a new Aster Capital Management position in Q3 2026.
Yarrow Bioscience made up 0.03% of Aster Capital Management's portfolio in Q3 2026, its #521 holding.
12 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.